| Nov 20 |
CalciMedica Announces Presentations at Upcoming Medical Meetings
|
| Nov 7 |
CalciMedica appoints Stephen Bardin as CFO
|
| Nov 7 |
CalciMedica Strengthens Leadership Team with Appointment of Stephen Bardin as Chief Financial Officer
|
| Oct 31 |
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
|
| Oct 31 |
CalciMedica Announces Pricing of Public Offering of Common Stock
|
| Oct 30 |
CalciMedica announces proposed public offering of common stock
|
| Oct 30 |
CalciMedica Announces Proposed Public Offering of Common Stock
|
| Oct 30 |
CalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
|
| Oct 28 |
CalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora™ in Acute Pancreatitis (AP)
|
| Sep 3 |
CalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
